Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy

Similar Items

• Influence of Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodiafiltration on the Disposition of Doripenem
  od: Cirillo, Iolanda, i dr.
  Izdano: (2011)
• Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill Patients
  od: Samtani, Mahesh N., i dr.
  Izdano: (2010)
• Population Pharmacokinetics of Doripenem Based on Data from Phase 1 Studies with Healthy Volunteers and Phase 2 and 3 Studies with Critically Ill Patients
  od: Nandy, Partha, i dr.
  Izdano: (2010)
• Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age
  od: Cirillo, Iolanda, i dr.
  Izdano: (2015)
• Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
  od: Jang, Soo Min, i dr.
  Izdano: (2020)